Date published: 2025-9-10

021-6093-6350

SCBT Portrait Logo
Seach Input

FLJ20433激活剂

The nomenclature FLJ20433 Activators implies a theoretical group of chemical compounds devised to enhance the activity of the protein encoded by the FLJ20433 gene. The FLJ acronym typically denotes full-length long Japan, a naming convention arising from a project aimed at discovering full-length long cDNA sequences in the Japanese population. Activators is purely speculative and does not correspond to any known chemical class. Should such a protein exist and be identified, activators would be molecules that interact with this protein to upregulate its function. These activators could potentially work by a variety of mechanisms, such as binding to the protein to stabilize its active form, increasing its expression through transcriptional regulation, or enhancing its interaction with other cellular components. The specific chemical properties of FLJ20433 Activators would depend significantly on the tertiary and quaternary structure of the FLJ20433 protein, as well as its role within the cellular machinery.

In the scenario of FLJ20433 Activators' development, the first step would be to ascertain the biological function of the FLJ20433 protein. This would likely entail a combination of genomic, proteomic, and bioinformatic techniques to map out the protein's structure, its domains of activity, and its cellular localization. Understanding the protein's role within the cell would be pivotal, and this could involve delving into its involvement in cellular processes, its interaction networks, and its regulation both at the genetic and post-translational levels. Once a comprehensive understanding of FLJ20433 is obtained, attention would turn to the chemical design of activators. These activators would be synthesized based on the structure of the protein and predicted interaction sites using computational chemistry and molecular modeling. The design process would also draw on knowledge from related proteins or homologous systems, where available. Subsequent experimental phases would involve in vitro and in vivo assays to test the compounds' efficacy in activating the FLJ20433 protein. These assays would measure not only the binding affinity and specificity of the activators but also their capacity to modulate the protein's activity in a controlled manner. Through this iterative process of hypothesis, design, synthesis, and testing, a class of FLJ20433 Activators could potentially be produced, offering insight into the biological function of the protein and serving as molecular probes for further scientific inquiry.

関連項目

产品名称CAS #产品编号数量价格应用排名

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

通过抑制核糖核苷酸还原酶造成 DNA 损伤,可能诱导包括 EXD3 在内的 DNA 修复酶。

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

形成 DNA 加合物,导致 DNA 损伤,从而上调 EXD3 等 DNA 修复蛋白。

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

通过抑制拓扑异构酶 II 诱导 DNA 链断裂,可能会增强 DNA 修复酶的表达。

Methyl methanesulfonate

66-27-3sc-250376
sc-250376A
5 g
25 g
$55.00
$130.00
2
(2)

烷化剂会造成 DNA 损伤,可能会触发包括 EXD3 在内的 DNA 修复途径的表达。

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

一种蒽环类化合物,可插入 DNA,造成损伤并可能诱导 DNA 修复机制。

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

交联 DNA,导致 DNA 修复活动增加,其中可能包括 EXD3 的表达。

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

抑制拓扑异构酶 I,导致 DNA 断裂,并可能上调 EXD3 等 DNA 修复酶。

Bleomycin

11056-06-7sc-507293
5 mg
$270.00
5
(0)

诱导 DNA 分裂,可能会增加参与 DNA 修复的基因(如 EXD3)的表达。

Benzo[a]pyrene

50-32-8sc-257130
1 g
$439.00
4
(1)

一种多环芳烃,会形成 DNA 加合物,可能诱导 DNA 修复基因的表达。

Acrylamide Solution, 40%

79-06-1sc-3721
1 L
$98.00
(1)

可形成 DNA 加合物,导致基因组损伤,从而可能上调 DNA 修复机制,包括 EXD3 的表达。